Cargando…

Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center

INTRODUCTION: Rituximab (RTX) is a therapeutic option in pediatric difficult-to-treat idiopathic nephrotic syndrome (NS). We aimed to assess the efficacy and safety of RTX use in these patients. METHOD: A retrospective study of all patients with idiopathic NS treated with RTX was conducted in a pedi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Rita, Mosca, Sara, Bastos-Gomes, Mariana, Correia-Costa, Liane, Rocha, Liliana, Teixeira, Ana, Costa, Teresa, Sameiro-Faria, Maria, Matos, Paula, Mota, Conceição
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697169/ https://www.ncbi.nlm.nih.gov/pubmed/36259942 http://dx.doi.org/10.1590/2175-8239-JBN-2022-0056en

Ejemplares similares

Genetic atypical hemolytic uremic syndrome in children: a 20-year experience from a tertiary center
por: Maximiano, Cristiana, et al.
Publicado: (2021)

Pediatric kidney transplant and cardiometabolic risk: a cohort study
por: Mosca, Sara, et al.
Publicado: (2022)

Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences
por: Belangero, Vera Maria Santoro
Publicado: (2023)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
por: Zurowska, Aleksandra, et al.
Publicado: (2023)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Effectiveness of rituximab in nephrotic syndrome treatment
por: Popko, Katarzyna, et al.
Publicado: (2017)

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort
por: Faria, Nuno, et al.
Publicado: (2021)

Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association
por: Lavrador, Vasco, et al.
Publicado: (2014)

Estimating the Glomerular Filtration Rate in Pediatric Patients With Neurogenic Bladder: A Comparison Between Creatinine- and Cystatin C-Equations
por: Menezes, Catarina, et al.
Publicado: (2023)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Evaluation protocol for amusia - portuguese sample
por: Peixoto, Maria Conceição, et al.
Publicado: (2015)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura
por: Nishikawa, Mana, et al.
Publicado: (2019)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Characterization of Occupational Exposure To Fungal Burden in Portuguese Bakeries
por: Viegas, Carla, et al.
Publicado: (2019)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Pharmacokinetics of cyclosporin - a microemulsion in children with idiopathic nephrotic syndrome
por: dos Santos Henriques, Luciana, et al.
Publicado: (2012)

Social and economic value of Portuguese community pharmacies in health care
por: Félix, Jorge, et al.
Publicado: (2017)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
por: Grenda, Ryszard, et al.
Publicado: (2016)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
por: Maratea, Dario, et al.
Publicado: (2016)

A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
por: Xu, Jing, et al.
Publicado: (2021)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
por: Song, Yiyun, et al.
Publicado: (2023)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
por: Zhang, Xiaojing, et al.
Publicado: (2022)

The contribution of Portuguese nursing to universal health access and coverage
por: Fernandes, Ananda Maria, et al.
Publicado: (2016)

Ponticelli regimen in idiopathic nephrotic syndrome
por: Das, U., et al.
Publicado: (2009)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome
por: Canetta, Pietro A. A., et al.
Publicado: (2015)

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017)

Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021)

Direct Costs of COVID-19 Inpatient Admissions in a Portuguese Tertiary Care University Centre
por: Seringa, Joana, et al.
Publicado: (2022)

469. Outcomes of COVID-19 among hospitalized patients under Rituximab: the experience of a Portuguese hospital
por: Gonçalves, Maria João M S, et al.
Publicado: (2023)

Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study
por: Soliman, Ahmed S.A., et al.
Publicado: (2022)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding
por: Simões, Roméo Rocha, et al.
Publicado: (2011)

Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome
por: Liu, Jialu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gckgl9pvbave3lfa7gbfpl5nja